Pharmaceutical Excipients Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type ; By Functionality ; By Application ; By End User ; By Region

Description

Global Pharmaceutical Excipients Market Size Expands at Significant CAGR of 5.82% to Reach USD 13.21 Billion by 2030

Global Pharmaceutical Excipients Market is flourishing because of the rising demand for pharmaceuticals and increasing shift towards generic drugs.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Pharmaceutical Excipients Market size at USD 8.89 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Pharmaceutical Excipients Market size to expand at a CAGR of 5.82% reaching a value of USD 13.21 billion by 2030. Growing demand for pharmaceutical products and generic medications and increasing investments in R&D programs to create innovative excipients, are key driving factors for the global pharmaceutical excipients market. An increasing emphasis on patient-centric formulations is also projected to drive the Global Pharmaceutical Excipients Market.

Opportunity: Launch of innovative pharmaceutical excipients

The rising investments in the R&D sector for the development of novel excipients and the launch of new products are anticipated to present lucrative growth opportunities to the global pharmaceutical excipients market during the forecast period. For instance, Roquette, a pharmaceutical and nutraceutical excipients manufacturer, launched three new excipient grades for moisture-sensitive active pharmaceutical ingredients. In another instance, Clariant, a multinational specialty chemical company based in Switzerland, introduced high performing pharmaceutical ingredients that allow for a wide range of active pharmaceutical ingredient (API) formulations and administration routes.

Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Excipients Market

The escalating geopolitical tensions negatively impacted the growth of the global pharmaceutical excipients market. For instance, Ukraine is a flourishing pharmaceutical excipient manufacturer and has been significantly investing in the field of medical research as well. However, Russia's invasion of Ukraine completely disrupted the growth of the Ukrainian pharmaceutical industry. The shortage of resources, supply chain disruption on Western borders, and seaport blockade due to the war led to low production capacities in the pharmaceutical industry, significantly altering the demand for pharmaceutical excipients as well. In addition, collaborative research projects and global alliances that are essential for medication development may come under pressure after the crisis in Ukraine, which might impede advancements in the sector.

Global Pharmaceutical Excipients Market

Segmental Coverage

Global Pharmaceutical Excipients Market - By Functionality

Based on functionality, the Global Pharmaceutical Excipients Market is segmented into fillers & diluents, binders, coating agents, flavoring agents, disintegrants, colorants, preservatives, and others. The binders segment accounts for the highest market share. Binders are added to formulations to increase bonding between particles or to give them flexibility. An essential function of binders is to enhance the grip of compounds in tablets and granules. They ensure that the formulations are created in the required quantity and physical strength. The function of pharmaceutical excipients as coating agents is anticipated to register the highest growth rate during the forecast period.

Global Pharmaceutical Excipients Market - By Region

The in-depth research report on the Global Pharmaceutical Excipients Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. Europe dominates the Global Pharmaceutical Excipients Market owing to the presence of major pharmaceutical manufacturers and rising excipient consumption in the region. The Asia Pacific region is anticipated to register the highest CAGR during the forecast period. These areas are also a rich source of raw materials for the production of excipients and facilitate low-cost manufacturing procedures, which drives overall market growth.

Competitive Landscape

Major players operating in the Global Pharmaceutical Excipients Market include Kerry Group plc, Merck KGaA, ADM, Dupont, Evonik Industries AG, Ashland Inc., Pharmaceutical Excipients, JRS PHARMA, Ankit Pulps and Boards Pvt Ltd, and Sigachi Industries.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Pharmaceutical Excipients Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Pharmaceutical Excipients Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC22111

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Excipients Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Rising Demand for Pharmaceuticals
  - 3.2.1.2. Increasing Shift towards Generic Drugs
- 3.2.2. Restraints
  - 3.2.2.1. High R&D and Production Costs
  - 3.2.2.2. Adverse Reactions of Excipients and Contamination in Formulations
- 3.2.3. Opportunities
  - 3.2.3.1. Development of Novel Excipients
  - 3.2.3.2. Rapid Advancements in Nanotechnology
- 3.2.4. Challenges
  - 3.2.4.1. Stringent Regulatory Requirements
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Excipients Market: Marketing Strategies

5. Global Pharmaceutical Excipients Market Overview

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Billion)
5.2. Market Share and Forecast
- 5.2.1. By Product Type
  - 5.2.1.1. Inorganic Chemicals
  - 5.2.1.2. Organic Chemicals
  - 5.2.1.3. Other Products
- 5.2.2. By Functionality
  - 5.2.2.1. Fillers and Diluents
  - 5.2.2.2. Binders
  - 5.2.2.3. Coating Agents
  - 5.2.2.4. Flavoring Agents
  - 5.2.2.5. Disintegrants
  - 5.2.2.6. Colorants
  - 5.2.2.7. Preservatives
  - 5.2.2.8. Others
- 5.2.3. By Application
  - 5.2.3.1. Parenteral Formulation
  - 5.2.3.2. Oral Formulations & Tablets
  - 5.2.3.3. Capsules
  - 5.2.3.4. Liquid & Injectables
  - 5.2.3.5. Nutraceuticals & OTC
  - 5.2.3.6. Topical Formulation
  - 5.2.3.7. Others
- 5.2.4. By End User
  - 5.2.4.1. Biopharma Industries
  - 5.2.4.2. Pharma Industries
  - 5.2.4.3. Animal Health
  - 5.2.4.4. Others
- 5.2.5. By Region
  - 5.2.5.1. North America
  - 5.2.5.2. Europe
  - 5.2.5.3. Asia Pacific (APAC)
  - 5.2.5.4. Latin America (LATAM)
  - 5.2.5.5. Middle East and Africa (MEA)

6. North America Pharmaceutical Excipients Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.2. By Functionality
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Country
  - 6.2.5.1. United States
  - 6.2.5.1.1. By Product Type
  - 6.2.5.1.2. By Functionality
  - 6.2.5.1.3. By Application
  - 6.2.5.1.4. By End User
  - 6.2.5.2. Canada
  - 6.2.5.2.1. By Product Type
  - 6.2.5.2.2. By Functionality
  - 6.2.5.2.3. By Application
  - 6.2.5.2.4. By End User

7. Europe Pharmaceutical Excipients Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Functionality
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
  - 7.2.5.1. Germany
  - 7.2.5.1.1. By Product Type
  - 7.2.5.1.2. By Functionality
  - 7.2.5.1.3. By Application
  - 7.2.5.1.4. By End User
  - 7.2.5.2. United Kingdom
  - 7.2.5.2.1. By Product Type
  - 7.2.5.2.2. By Functionality
  - 7.2.5.2.3. By Application
  - 7.2.5.2.4. By End User
  - 7.2.5.3. Italy
  - 7.2.5.3.1. By Product Type
  - 7.2.5.3.2. By Functionality
  - 7.2.5.3.3. By Application
  - 7.2.5.3.4. By End User
  - 7.2.5.4. France
  - 7.2.5.4.1. By Product Type
  - 7.2.5.4.2. By Functionality
  - 7.2.5.4.3. By Application
  - 7.2.5.4.4. By End User
  - 7.2.5.5. Spain
  - 7.2.5.5.1. By Product Type
  - 7.2.5.5.2. By Functionality
  - 7.2.5.5.3. By Application
  - 7.2.5.5.4. By End User
  - 7.2.5.6. Belgium
  - 7.2.5.6.1. By Product Type
  - 7.2.5.6.2. By Functionality
  - 7.2.5.6.3. By Application
  - 7.2.5.6.4. By End User
  - 7.2.5.7. Russia
  - 7.2.5.7.1. By Product Type
  - 7.2.5.7.2. By Functionality
  - 7.2.5.7.3. By Application
  - 7.2.5.7.4. By End User
  - 7.2.5.8. The Netherlands
  - 7.2.5.8.1. By Product Type
  - 7.2.5.8.2. By Functionality
  - 7.2.5.8.3. By Application
  - 7.2.5.8.4. By End User
  - 7.2.5.9. Rest of Europe
  - 7.2.5.9.1. By Product Type
  - 7.2.5.9.2. By Functionality
  - 7.2.5.9.3. By Application
  - 7.2.5.9.4. By End User

8. Asia Pacific Pharmaceutical Excipients Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Functionality
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
  - 8.2.5.1. China
  - 8.2.5.1.1. By Product Type
  - 8.2.5.1.2. By Functionality
  - 8.2.5.1.3. By Application
  - 8.2.5.1.4. By End User
  - 8.2.5.2. India
  - 8.2.5.2.1. By Product Type
  - 8.2.5.2.2. By Functionality
  - 8.2.5.2.3. By Application
  - 8.2.5.2.4. By End User
  - 8.2.5.3. Japan
  - 8.2.5.3.1. By Product Type
  - 8.2.5.3.2. By Functionality
  - 8.2.5.3.3. By Application
  - 8.2.5.3.4. By End User
  - 8.2.5.4. South Korea
  - 8.2.5.4.1. By Product Type
  - 8.2.5.4.2. By Functionality
  - 8.2.5.4.3. By Application
  - 8.2.5.4.4. By End User
  - 8.2.5.5. Australia & New Zealand
  - 8.2.5.5.1. By Product Type
  - 8.2.5.5.2. By Functionality
  - 8.2.5.5.3. By Application
  - 8.2.5.5.4. By End User
  - 8.2.5.6. Indonesia
  - 8.2.5.6.1. By Product Type
  - 8.2.5.6.2. By Functionality
  - 8.2.5.6.3. By Application
  - 8.2.5.6.4. By End User
  - 8.2.5.7. Malaysia
  - 8.2.5.7.1. By Product Type
  - 8.2.5.7.2. By Functionality
  - 8.2.5.7.3. By Application
  - 8.2.5.7.4. By End User
  - 8.2.5.8. Singapore
  - 8.2.5.8.1. By Product Type
  - 8.2.5.8.2. By Functionality
  - 8.2.5.8.3. By Application
  - 8.2.5.8.4. By End User
  - 8.2.5.9. Vietnam
  - 8.2.5.9.1. By Product Type
  - 8.2.5.9.2. By Functionality
  - 8.2.5.9.3. By Application
  - 8.2.5.9.4. By End User
  - 8.2.5.10. Rest of APAC
  - 8.2.5.10.1. By Product Type
  - 8.2.5.10.2. By Functionality
  - 8.2.5.10.3. By Application
  - 8.2.5.10.4. By End User

9. Latin America Pharmaceutical Excipients Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Functionality
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
  - 9.2.5.1. Brazil
  - 9.2.5.1.1. By Product Type
  - 9.2.5.1.2. By Functionality
  - 9.2.5.1.3. By Application
  - 9.2.5.1.4. By End User
  - 9.2.5.2. Mexico
  - 9.2.5.2.1. By Product Type
  - 9.2.5.2.2. By Functionality
  - 9.2.5.2.3. By Application
  - 9.2.5.2.4. By End User
  - 9.2.5.3. Argentina
  - 9.2.5.3.1. By Product Type
  - 9.2.5.3.2. By Functionality
  - 9.2.5.3.3. By Application
  - 9.2.5.3.4. By End User
  - 9.2.5.4. Peru
  - 9.2.5.4.1. By Product Type
  - 9.2.5.4.2. By Functionality
  - 9.2.5.4.3. By Application
  - 9.2.5.4.4. By End User
  - 9.2.5.5. Rest of LATAM
  - 9.2.5.5.1. By Product Type
  - 9.2.5.5.2. By Functionality
  - 9.2.5.5.3. By Application
  - 9.2.5.5.4. By End User

10. Middle East and Africa Pharmaceutical Excipients Market

10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Functionality
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
  - 10.2.5.1. Saudi Arabia
  - 10.2.5.1.1. By Product Type
  - 10.2.5.1.2. By Functionality
  - 10.2.5.1.3. By Application
  - 10.2.5.1.4. By End User
  - 10.2.5.2. UAE
  - 10.2.5.2.1. By Product Type
  - 10.2.5.2.2. By Functionality
  - 10.2.5.2.3. By Application
  - 10.2.5.2.4. By End User
  - 10.2.5.3. Qatar
  - 10.2.5.3.1. By Product Type
  - 10.2.5.3.2. By Functionality
  - 10.2.5.3.3. By Application
  - 10.2.5.3.4. By End User
  - 10.2.5.4. Kuwait
  - 10.2.5.4.1. By Product Type
  - 10.2.5.4.2. By Functionality
  - 10.2.5.4.3. By Application
  - 10.2.5.4.4. By End User
  - 10.2.5.5. South Africa
  - 10.2.5.5.1. By Product Type
  - 10.2.5.5.2. By Functionality
  - 10.2.5.5.3. By Application
  - 10.2.5.5.4. By End User
  - 10.2.5.6. Nigeria
  - 10.2.5.6.1. By Product Type
  - 10.2.5.6.2. By Functionality
  - 10.2.5.6.3. By Application
  - 10.2.5.6.4. By End User
  - 10.2.5.7. Algeria
  - 10.2.5.7.1. By Product Type
  - 10.2.5.7.2. By Functionality
  - 10.2.5.7.3. By Application
  - 10.2.5.7.4. By End User
  - 10.2.5.8. Rest of MEA
  - 10.2.5.8.1. By Product Type
  - 10.2.5.8.2. By Functionality
  - 10.2.5.8.3. By Application
  - 10.2.5.8.4. By End User

11. Competitive Landscape

11.1. List of Key Players and Their Offerings
11.2. Global Pharmaceutical Excipients Market Share Analysis, 2023
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Geopolitical Tension in Global Pharmaceutical Excipients Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

13.1. Kerry Group plc.
13.2. Merck KGaA
13.3. ADM
13.4. Dupont
13.5. Evonik Industries AG
13.6. Ashland Inc
13.7. Pharmaceutical Excipients
13.8. JRS PHARMA
13.9. Ankit Pulps and Boards Pvt Ltd
13.10. Sigachi Industries
13.11. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumptions & Limitations